Immunotherapy of allergic diseases using probiotics or recombinant probiotics - Archive ouverte HAL
Article Dans Une Revue Journal of Applied Microbiology Année : 2013

Immunotherapy of allergic diseases using probiotics or recombinant probiotics

Résumé

Allergic diseases affect up to 30% of the western population, and their prevalence is increasing. Probiotics are able to modulate the mucosal immune response, and clinical trials demonstrated that specific strains, especially lactic acid bacteria (LAB) ones, reduce allergic symptoms. Moreover, the use of recombinant probiotics has been evaluated as possible strategies for the immunotherapy of allergic diseases. The production and delivery of allergens by recombinant Lin concert with their ability to induce a Th1-type immune response have been shown to be a promising mucosal vaccination strategy in mouse model. The aim of this article is to review the applications of probiotics in allergy immunotherapy with a special focus on recombinant Ldelivering proteins or DNA.
Fichier non déposé

Dates et versions

hal-01001031 , version 1 (04-06-2014)

Identifiants

Citer

Marcela M. de Azevedo, Silvia S. Innocentin, F. A. F. A. Dorella, C. S. C. S. Rocha, Denis Mariat, et al.. Immunotherapy of allergic diseases using probiotics or recombinant probiotics. Journal of Applied Microbiology, 2013, 115 (2), pp.319 - 333. ⟨10.1111/jam.12174⟩. ⟨hal-01001031⟩
137 Consultations
0 Téléchargements

Altmetric

Partager

More